Magnitude of tolerance to fentanyl is independent of μ-opioid receptor density

European Journal of Pharmacology

Volumn 319, Issue 2-3, 1997, Pages 225-228

  Chan, Ka Wa ^a   Duttory, Alokesh ^a   Yoburn, Byron C ^a  

^a ST JOHN'S UNIVERSITY   (United States)

Author keywords

Opioid receptor; Analgesia; Cloccinamox; DAMGO ( D Ala2, MePhe4, Gly(ol)5 enkephalin); Downregulation; Fentanyl; Tolerance

Indexed keywords

CLOCINNAMOX; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; FENTANYL; MU OPIATE RECEPTOR; PLACEBO;

ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG TOLERANCE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; SUBCUTANEOUS DRUG ADMINISTRATION;

ANALGESICS; ANIMALS; BRAIN CHEMISTRY; CINNAMATES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DRUG IMPLANTS; DRUG TOLERANCE; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALINS; FENTANYL; KINETICS; MALE; MICE; MORPHINE DERIVATIVES; NARCOTIC ANTAGONISTS; NARCOTICS; PAIN MEASUREMENT; REACTION TIME; RECEPTORS, OPIOID, MU;

EID: 0031016083     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00960-0     Document Type: Article

References (21)

1. Aceto, M.D., E.R. Bowman, E.L. May, L.S. Harris, J.H. Woods, C.B. Smith, F. Medzihradsky and A.E. Jacobson, 1989, Very long-acting narcotic antagonists: the 14β-p-substituted cinnamoylaminomorphinones and their partial μ agonist codeinone relatives, Arzneim.-Forsch./Drug Res. 39, 570.
2. Bradford, M.M., 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 72, 248.
3. Burke, T.F., J.H. Woods, J.W. Lewis and F. Medzihradsky, 1994, Irreversible opioid antagonist effects of clocinnamox on opioid analgesia and mu receptor binding in mice, J. Pharmacol. Exp. Ther. 271, 715.
4. Chan, K., M. Brodsky, T. Davis, S. Franklin, C.E. Inturrisi and B.C. Yoburn, 1995, The effect of the irreversible μ-opioid receptor antagonist clocinnamox on morphine potency, receptor binding and receptor mRNA, Eur. J. Pharmacol. 287, 135.
5. Comer, S.D., T.F. Burke, J.W. Lewis and J.H. Woods, 1992, Clocinnamox: a novel, systemically-active, irreversible opioid antagonist, J. Pharmacol. Exp. Ther. 262, 1051.
6. Duttaroy, A. and B.C. Yoburn, 1995, The effect of intrinsic efficacy on opioid tolerance, Anesthesiology 82, 1226.
7. Finney, D.J., 1973, Probit Analysis, 3rd edn. (Cambridge University Press, London).
8. France, C.P., L.R. Gerak, D. Flynn, G.D. Winger, F. Medzihradsky, J.R. Bagley, L.L. Brockunier and J. Woods, 1995, Behavioral effects and receptor binding affinities of fentanyl derivatives in rhesus monkeys, J. Pharmacol. Exp. Ther. 274, 17.
9. Inturrisi, C.E., 1990, Opioid analgesic therapy in cancer pain, in: Advances in Pain Research and Therapy, eds. K.M. Foley, J.J. Bonica and V. Ventafridda (Raven Press, New York, NY) p. 133.
10. Kenakin, T., 1993, Pharmacologic Analysis of Drug-Receptor Interaction, 2nd edn. (Raven Press, New York, NY).
11. Loh, H.H., P.-L. Tao and A.P. Smith, 1988, Invited review: Role of receptor upregulation in opioid tolerance mechanisms, Synapse 2, 413.
12. Lutfy, K. and B.C. Yoburn, 1991, The role of opioid receptor density in morphine tolerance, J. Pharmacol. Exp. Ther. 256, 575.
13. Maguire, P., N. Tsai, J. Kamal, C. Cometta-Morini, C. Upton and G. Loew, 1992, Pharmacological profiles of fentanyl analogs at μ, δ and κ opiate receptors, Eur. J. Pharmacol. 213, 219.
14. Puttfarcken, P.S. and B.M. Cox, 1989, Morphine-induced desensitization and down-regulation in mu-receptors in 7315c pituitary tumor cells, Life Sci. 45, 1937.
15. Tao, P.-L., P.Y. Law and H.H. Loh, 1987, Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment, J. Pharmacol. Exp. Ther. 240, 809.
16. Tao, P.-L., H.-Y. Lee, L.-R. Chang and H.H. Loh, 1990, Decrease in μ-opioid receptor binding capacity in rat brain after chronic PL017 treatment, Brain Res. 526, 270.
17. Yoburn, B.C., V. Sierra and K. Lufty, 1989a, Chronic opioid antagonist treatment: assessment of receptor regulation, Eur. J. Pharmacol. 170, 193.
18. Yoburn, B.C., S.P. Kreuscher, C.E. Inturrisi and V. Sierra, 1989b, Opioid receptor upregulation and supersensitivity in mice: effect of morphine sensitivity, Pharmacol. Biochem. Behav. 32, 727.
19. Yoburn, B.C., B. Barbara and A. Duttaroy, 1993, Opioid receptor regulation in mice, J. Pharmacol. Exp. Ther. 265, 314.
20. Yoburn, B.C., S. Shah, K. Chan, A. Duttaroy and T. Davis, 1995, Supersensitivity to opioid analgesics following chronic opioid antagonist treatment: relationship to receptor selectivity, Pharmacol. Biochem. Behav. 51, 535.
21. Zernig, G., E.R. Butelman, J.W. Lewis, E.A. Walker and J.H. Woods, 1994, In vivo determination of mu opioid receptor turnover in rhesus monkeys after irreversible blockade with clocinnamox, J. Pharmacol. Exp. Ther. 269, 57.